{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:52:58Z","timestamp":1655470378629},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.crohns.2011.08.017","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T06:42:46Z","timestamp":1316760166000},"page":"649","source":"Crossref","is-referenced-by-count":7,"title":["Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau"],"prefix":"10.1093","volume":"5","author":[{"given":"Fabio","family":"Caputo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Parro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2011.08.017_bb0005","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2011.08.017_bb0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2011.58","article-title":"An evidence-based systematic review on medical therapies for inflammatory bowel disease","volume":"106","author":"Talley","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.08.017_bb0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000277415","article-title":"Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review","volume":"220","author":"Puig","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.crohns.2011.08.017_bb0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1517\/14712598.2010.500283","article-title":"The therapeutic potential of TNF-alpha antagonists for skin psoriasis comorbidities","volume":"10","author":"Pi\u00e9rard","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.crohns.2011.08.017_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.crohns.2010.11.001","article-title":"Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect","volume":"5","author":"Iborra","year":"2011","journal-title":"J Crohns Colitis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611002480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/5\/6\/649\/7800637\/5-6-649.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T04:53:44Z","timestamp":1503464024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2011.08.017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1873994611002480"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2011.08.017","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}